Evidence for cell-specific Nrf2 activation in animal models of multiple sclerosis is more scarce than in post-mortem human tissue, perhaps reflecting the variability of Nrf2 activity in these studies. This evidence concerns the gene NFE2L2 and multiple sclerosis.